Human Immunodeficiency Virus Pathogenesis and Prospects for Immune Control in Patients with Established Infection

Mayer, Kenneth H.; Cohen, Daniel E.; Walker, Bruce D.
June 2001
Clinical Infectious Diseases;6/15/2001, Vol. 32 Issue 12, p1756
Academic Journal
Focuses on the clinical implications of advances in understanding HIV-1 pathogenesis, with particular emphasis on the role of immune responses in controlling viremia. Natural history of acute HIV infection; Clinical manifestations of acute HIV-1 infection; Viral and host factors that influence disease progression; Critical role of the immune system in disease progression.


Related Articles

  • Human Immunodeficiency Virus Type 1 Infection, Mucosal Immunity, and Pathogenesis and Extramural... Kresina, Thomas F.; Mathieson, Bonnie // Journal of Infectious Diseases;5/15/99 Supplement 3, Vol. 179, pS392 

    Discusses the interactions of HIV with M cells and other cells of the mucosa in infection and as part of the pathogenesis of HIV infection. Transmission of HIV via mucosal surfaces; Generation of protective immunity; Role of the gastrointestinal tract in HIV infection; Overview of research...

  • Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Pope, Melissa; Haase, Ashley T // Nature Medicine;Jul2003, Vol. 9 Issue 7, p847 

    By the acute stage of HIV-1 infection, the immune system already faces daunting challenges. Research on mucosal barriers and the events immediately after heterosexual transmission that precede this acute stage could facilitate the development of effective microbicides and vaccines.

  • Fatal Immune Restoration Disease in Human Immunodeficiency Virus Type 1--Infected Patients with Progressive Multifocal Leukoencephalopathy: Impact of Antiretroviral Therapy--Associated Immune Reconstitution. Safdar, Amar; Rubocki, Ronald J.; Horvath, Joseph A.; Narayan, Kailash K.; Waldron, Robert L. // Clinical Infectious Diseases;11/15/2002, Vol. 35 Issue 10, p1250 

    Immune reconstitution resulting from use of highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 1 (HIV-1) has been associated with a significant decrease in infectious morbidity and with improved survival. Occasionally, patients with quiescent disease...

  • HIV tropism and CD4+ T-cell depletion. Hellerstein, Marc // Nature Medicine;Jun2002, Vol. 8 Issue 6, p537 

    Discusses the critical role of immune activation in HIV-1 pathogenesis. Analysis of conclusions of the study conducted by Gossman et al.; Destruction of CD4[sup+] T-cells by HIV-1; Emphasis on the study of phenotype of HIV-1 strains that are present in infected humans; Reasons for understanding...

  • Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. Bogden, John D.; Kemp, Francis W. // American Journal of Clinical Nutrition;Sep2000, Vol. 72 Issue 3, p809 

    Assesses relations among HIV-1 progression and nutritional and demographic variables. Dependence of immune function on nutritional status due to the large mass and high rate of cellular turnover of the immune system, making it a major user of nutrients; Evidence compromising nutritional and...

  • Multiple myeloma as the first manifestation of acquired immunodeficiency syndrome: a case report and review of the literature. Pouli, A.; Lemessiou, H.; Rontogianni, D.; Papanastassiou, C.; Tsakanikas, S.; Gerassimou, A.; Stamatelou, M. // Annals of Hematology;Sep2001, Vol. 80 Issue 9, p557 

    Various hematologic malignancies and solid tumors are increasingly diagnosed in patients with human immunodeficiency virus (HIV) infection and may be the presenting manifestation of acquired immunodeficiency syndrome (AIDS). Multiple myeloma, however, has never been reported as the presenting...

  • Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection. Crowell, Trevor A.; Gebo, Kelly A.; Blankson, Joel N.; Korthuis, P. Todd; Yehia, Baligh R.; Rutstein, Richard M.; Moore, Richard D.; Sharp, Victoria; Nijhawan, Ank E.; Mathews, W. Christopher; Hanau, Lawrence H.; Corales, Roberto B.; Beil, Robert; Somboonwit, Charurut; Edelstein, Howard; Allen, Sara L.; Berry, Stephen A. // Journal of Infectious Diseases;6/1/2015, Vol. 211 Issue 11, p1692 

    Background. Elite controllers spontaneously suppress human immunodeficiency virus (HIV) viremia but also demonstrate chronic inflammation that may increase risk of comorbid conditions. We compared hospitalization rates and causes among elite controllers to those of immunologically intact persons...

  • Chemokines and Their Receptors in Central Nervous System Disease. Biber, Knut; de Jong, Eiko K.; van Weering, Hilmar R.J.; Boddeke, Hendrikus W. G. M. // Current Drug Targets;Jan2006, Vol. 7 Issue 1, p29 

    Almost a decade ago, it was discovered that the human deficiency virus (HIV) makes use of chemokine receptors to infect blood cells. This appreciation of the clinical relevance of specific chemokine receptors has initiated a considerable boost in the field of chemokine research. It is clear...

  • Viral burden in AIDS. McLean, Angela; Michie, Colin // Nature;9/23/1993, Vol. 365 Issue 6444, p301 

    Presents reactions to an article in the 1993 volume 364, issue 291 of `Nature' by H.W. Sheppard and colleagues. Direct virus mediated acquired immune deficiency syndrome (AIDS); Low prevalence of HIV-infected cells; Regeneration of human immune systems; Ineffectiveness of HIV disease drugs;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics